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Abstract After having undergone surgical correction at an
early age, many patients with tetralogy of Fallot develop
long-term complications including progressive pulmonary
regurgitation and peripheral pulmonary stenosis. A high
percentage of these patients need to undergo a second
operation in their adolescence or early adulthood. If
simultaneous treatment of both pulmonary regurgitation
and peripheral pulmonary stenosis is warranted, a complete
surgical approach has several disadvantages. We describe
four cases of Fallot patients with severe pulmonary
regurgitation and peripheral pulmonary stenosis who were
treated using a hybrid approach involving surgical implan-
tation of a pulmonary homograft and peroperative stenting
of the pulmonary artery.
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During the first decennia of cardiac surgery (1960s and
1970s), neonates born with tetralogy of Fallot were
typically treated at a young age with a surgical shunt
between the aorta and pulmonary artery to increase
pulmonary blood flow and thus oxygenation, as a bridge
to complete correction. A technique frequently used at that
time was a direct anastomosis between the ascending aorta
and the right PA at the side where they cross, a so-called
Waterston shunt. Complete surgical correction was then
performed in the first years of life and involved taking
down the shunt, closure of the ventricular septum defect
and relief of the pulmonary valve stenosis with or without a
transannular patch [1, 2].
The most common long-term complication after com-
plete surgical correction of tetralogy of Fallot is progressive
pulmonary regurgitation. Pulmonary valve replacement is
indicated when patients become symptomatic and/or in case
of progressive dilatation and dysfunction of the right
ventricle. [3] Another long-term complication is the
development of peripheral stenosis of the right pulmonary
artery at the previous anastomosis site of the Waterston
shunt. Frequently, the severity of pulmonary regurgitation
and its deleterious long-term effects are augmented by co-
existing pulmonary artery stenosis and should therefore be
addressed at the time of surgery.
Pulmonary valve replacement with a homograft is a low-
risk procedure which can usually be performed on a beating
heart with a short cardiopulmonary bypass (CPB) run.
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Simultaneous treatment of peripheral pulmonary artery
stenosis, especially when due to a previous Waterston
shunt, is a more challenging surgical task, with disappoint-
ing long-term results [4]. The surgical approach requires
aortic clamping, cardioplegia and often transsection of the
aorta, which is associated with additional periprocedural
risk. Even if a good initial result is achieved, any patch-
plasty of the right PA branch is immediately compromised
by the, often mildly dilated, ascending aorta and by scarring
in the long term.
In this report we present four tetralogy of Fallot patients
with severe pulmonary regurgitation and peripheral stenosis
of the right branch of the pulmonary artery who underwent
a hybrid strategy with surgical pulmonary valve replace-
ment with a homograft and peroperative stenting to treat the
peripheral pulmonary artery stenosis.
Patients
At neonatal age, all patients were palliated with a Waterston
shunt to increase pulmonary blood flow. When they were
toddlers, the shunt was taken down and total surgical repair
was performed with enlargement of the hypoplastic
pulmonary trunk using a transannular patch (except in Case
C where no transannular patch was used). All patients
gradually developed severe pulmonary regurgitation and
progressive right ventricular dilatation and dysfunction, as
well as a significant stenosis of the right pulmonary artery
at the anastomosis site of the former Waterston shunt.
Case Awas a male patient of 39 years who was transferred
from a referring hospital for management of severe pulmonary
regurgitation and sustained ventricular tachycardia with a left
bundle branch morphology and an inferior axis. He was
known to have severe pulmonary regurgitation but had been
asymptomatic until admission. Echocardiography showed
severe pulmonary regurgitation and a dilated right ventricle
with preserved systolic function.
Case B was a 38-year-old female who had visited our
outpatient clinic on a regular basis since early childhood. At
the age of 14 she was diagnosed with moderate pulmonary
valve stenosis and regurgitation. The right ventricular
pressure at that time was 70/12 mmHg as a consequence
of stenoses in both the right and left pulmonary artery
branches (gradient 20 mmHg and 35 mmHg, respectively)
in combination with moderate pulmonary valve stenosis.
She had been completely asymptomatic and was managed
conservatively. At the age of 31, pulmonary regurgitation
had become severe but there were still no echocardiographic
signs of dilatation or dysfunction of the right ventricle. At the
age of 39, cardiac MRI showed a significant increase of right
ventricular end-diastolic and end-systolic volumes within one
year and confirmed severe pulmonary regurgitation.
Case C was a female patient with tetralogy of Fallot who
had given birth to twins without any cardiac complications.
She visited the outpatient clinic on a regular basis because
of moderate pulmonary regurgitation with normal dimen-
sions and function of the right ventricle. She was
asymptomatic until the age of 36. She gradually developed
right ventricular systolic dysfunction due to severe pulmonary
regurgitation in combination with pulmonary valve stenosis as
well as stenosis of the right and left pulmonary artery
branches. Her exercise capacity gradually deteriorated and
she developed signs of right-sided heart failure.
Case D was a female tetralogy of Fallot patient who had
undergone total correction at the age of 5. At the age of 12,
she had developed severe stenosis of the right branch of the
pulmonary artery (gradient 75 mmHg) which was treated
with surgical patch-plasty. She remained asymptomatic until
the age of 37. At the age of 37 her exercise capacity
deteriorated. MRI showed progression of right ventricular
dilatation, impaired right ventricular systolic function,
severe pulmonary regurgitation, an aneurysmatic right
ventricular outflow tract (RVOT) and severe ostial stenosis
of the right pulmonary artery branch.
The hybrid procedures
The hybrid procedure combines surgical and interventional
techniques. All procedures were performed on CPB. The
pulmonary trunkwas incised longitudinally and the pulmonary
artery branches were visualised directly. The length of the stent
was selected on the basis of the vessel diameter as visualised
by preoperative imaging (angiography and MRI in particular),
the location of the stenosis, and peroperative anatomical
findings. The CPZ8 stent allows expansion from 8.0 mm to
24.0 mm. The CPZ8 stent was hand-crimped on a SHYTAK II
balloon and placed across the lesion by the interventional
cardiologist. The stent was inflated according to manufac-
turer’s guidelines. Positioning of the stent was done under
direct vision of the proximal part of the stent and the distal
aspect was palpated digitally to ensure that the stent would not
compromise the ostium of the right upper lobe branch.
In all patients, a pulmonary homograft was used to
replace the pulmonary valve and pulmonary trunk. Addi-
tional reconstruction of the aneurysmatic RVOT was
performed in Cases A, B and D.
In Case A, the procedure was performed on a beating heart.
Predilatation was performed using a 12 mm balloon (6 atm)
using an Amplatzer stiff guidewire. The length of the CPZ8
stent was 28 mm; after balloon inflation the diameter of the
stent was 15 mm (4 atm). The CPB time was 136 min.
In Case B, predilatation was performed using a 12 mm
balloon (6 atm) using an Amplatzer stiff guidewire. The
length of the CPZ8 stent was 22 mm, after balloon inflation
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the diameter of the stent was 14 mm (4 atm). The proximal
part of the stent was post-dilated to 18 mm to assure good
fit. The CPB time was 85 min.
In Case C, a CPZ8 stent (length 34 mm) was positioned
across the severely stenotic proximal right pulmonary
artery. After balloon inflation (4 atm) the diameter of the
stent was 15 mm. The position of the stent was good, but
waisting of the stent was seen in the middle section of the
stent. Therefore the stent was post-dilated (8 atm). The
procedure was complicated by a tear of the right pulmonary
artery at the distal end of the stent for which aortic
clamping was necessary for 25 min. The right pulmonary
artery was repaired successfully using a triangular patch.
The proximal left pulmonary artery stenosis was repaired
with the use of the homograft. The CPB time was 146 min.
In Case D, femoral cannulation was necessary because
of severe adhesions as a consequence of previous oper-
ations. Aortic clamping of 47 min was necessary because of
excessive collateral flow and for optimal exposition of the
right pulmonary artery ostium. The length of the CP stent
was 22 mm, after balloon inflation (4 atm) the diameter of
the stent was 12 mm. The CPB time was 147 min.
Follow-up
In all patients, a dramatic improvement of right ventricular
systolic function was observed, allowing weaning from
inotropic support and artificial ventilation within a few hours
after the procedure. Postoperative echocardiography showed
mild pulmonary regurgitation and an improvement of right
ventricular dimensions and function in all patients. After 3 years
of follow-up, Case A, B and C patients are still asymptomatic.
Case D is also asymptomatic but follow-up is only 2 months.
Discussion
In all cases, the stenosis of the right pulmonary artery was
located at the site of the formerWaterston shunt. Soon after the
introduction of this surgical technique it was recognised that
the Waterston shunt was associated with problems such as
kinking of the pulmonary artery, pulmonary overflow with
congestive heart failure and eventually pulmonary vascular
disease. Take-down of the shunt was performed by direct
suturing from inside the aorta, simple ligation or detachment
and patch-plasty of the right pulmonary artery branch.
Irrespective of the surgical technique used, there is a high
incidence of severe obstruction of the right pulmonary artery
due to scarring in combination with compression by the
ascending aorta. [4] Due to the short-term and long-term
complications associated with the Waterston shunt, this
technique was abandoned and other shunt techniques were
introduced, such as the modified Blalock-Taussig shunt.
Over the past two decades, further developments in surgical
techniques and perioperative care have led to a tendency
towards primary correction at young age.
Nowadays in our centre, primary correction is performed
between 3 and 6 months and a shunt is avoided whenever
possible. Only in case of severe hypoplasia of the PA
branches and/or tree or in case of unfavourable RVOT
anatomy (a long and severely obstructive infundibulum
requiring a long transannular patch) is an initial modified
Blalock-Taussig shunt still used.
Percutaneous stenting of the pulmonary artery was
introduced in 1991 [5]. Subsequent follow-up studies
demonstrated that stents maintain long-term vessel patency
and can be dilated further at subsequent catheterisation. [6–
9] Percutaneous stenting is now an established treatment
modality for older children and adults with branch
pulmonary artery stenosis [10, 11], although high rates of
early complications are reported [12].
Intra-operative placement of stents under direct vision as
a hybrid procedure has nowadays completed the spectrum
of pulmonary artery stenting. A hybrid procedure shortens
CPB time and avoids the need for hypothermia and
transsection of the ascending aorta and for patch-plasty of
the right pulmonary artery. Furthermore, complications of
percutaneous stent placement, such as haemodynamic
instability and vascular tear, can be avoided or easily
addressed in the operative setting with CPB, thereby
making the procedure safe and effective. [13–18]
Close collaboration between cardiac surgeons, imaging
and interventional cardiologists is essential in the modern
management of congenital heart defects. The hybrid
approach described above is an example of how this can
be accomplished. In our CAHAL collaboration between
Amsterdam Medical Centre, Leiden University Medical
Centre and the VU University Medical Centre, the hybrid
procedure was shown to be a safe and effective treatment
option for patients with severe pulmonary regurgitation and
stenosis of the pulmonary arteries. Long-term follow-up of
stented patients will be necessary to establish the long-term
impact of this hybrid procedure.
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